T M C Hospice Aka Peppi's House in Tucson, Arizona

T M C Hospice Aka Peppi's House is a medicare-certified hospice facility in Tucson, Arizona. It is a other hospice and this hospice is a Part of a hospital. It is located at 2715 North Wyatt Drive in Tucson, Arizona. You can reach out to the office of T M C Hospice Aka Peppi's House via phone at (520) 324-1027.

T M C Hospice Aka Peppi's House is first approved in July, 1992 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 031514. San Francisco is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


T M C Hospice Aka Peppi's House
2715 North Wyatt Drive, Tucson, AZ, 85712
(520) 324-1027

News Archive

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

Scientists identify novel mechanism that can reorganize cell's genetic architecture to promote senescence

Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin Pharmaceuticals, Inc. today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy.

Read more Medical News

› Verified 6 days ago

Map and Direction



Hospice Profile

NameT M C Hospice Aka Peppi's House
Location2715 North Wyatt Drive, Tucson, Arizona
Hospice ID031514
CategoryPart of a hospital
Ownership TypeOther
Profit TypeOTHER
Accreditation ProviderThe Joint Commission (TJC)
SSA county code090

News Archive

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

Scientists identify novel mechanism that can reorganize cell's genetic architecture to promote senescence

Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin Pharmaceuticals, Inc. today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy.

Read more Medical News

› Verified 6 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with T M C Hospice Aka Peppi's House from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Quality of Patient Care at T M C Hospice Aka Peppi's House

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. T M C Hospice Aka Peppi's House has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care100.098.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care98.093.6
Patients who were checked for pain at the beginning of hospice care76.893.9
Patients who got a timely and thorough pain assessment when pain was identified as a problem83.877.7
Patients who were checked for shortness of breath at the beginning of hospice care98.397.3
Patients who got timely treatment for shortness of breath97.094.6
Patients taking opioid pain medication who were offered care for constipation94.293.3

News Archive

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

Scientists identify novel mechanism that can reorganize cell's genetic architecture to promote senescence

Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin Pharmaceuticals, Inc. today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy.

Read more Medical News

› Verified 6 days ago


Services Provided by T M C Hospice Aka Peppi's House:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by T M C Hospice Aka Peppi's House below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Medical Social Service
    • Medical Supply Service
    • Nursing Service
    • Physician Service
    • Short Term Inpatient care

  • Under Arrangement
    • Occupational Therapy
    • Physical Therapy
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at T M C Hospice Aka Peppi's House
Home Health Aides10
Counselors3
Licensed Practical or Vocational Nurses1
Medical Social Workers 6
Physicians1
Registered Nurses29
Other Personnel6
Total Employees56

News Archive

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

Scientists identify novel mechanism that can reorganize cell's genetic architecture to promote senescence

Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin Pharmaceuticals, Inc. today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy.

Read more Medical News

› Verified 6 days ago


Number of Full-time equivalent Volunteers:

Others5
Total Volunteers5

News Archive

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

Scientists identify novel mechanism that can reorganize cell's genetic architecture to promote senescence

Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous.

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin Pharmaceuticals, Inc. today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy.

Read more Medical News

› Verified 6 days ago

Certification Details for T M C Hospice Aka Peppi's House:

  • May, 2018 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is eligible to participate in the medicare and/or medicaid program.
  • Blue Cross (california) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 31, December.
  • Related Provider Number is 030006.

Hospices in Tucson

Amedisys Hospice
Location: 5185 East River Road, Suite 201, Tucson, Arizona, 85718
Phone: (520) 324-1027
T M C Hospice Aka Peppi's House
Location: 2715 North Wyatt Drive, Tucson, Arizona, 85712
Phone: (520) 324-1027
Hospice Family Care, Inc. - Tucson
Location: 6300 East El Dorado Plaza, A-100, Tucson, Arizona, 85715
Phone: (520) 324-1027
Kindred Hospice
Location: 5210 East Williams Circle, Suite 100, Tucson, Arizona, 85711
Phone: (520) 324-1027

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.